Major pathologic response and long-term clinical benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative breast cancer after neoadjuvant chemotherapy
Article in The Breast (August 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in The Breast (August 2024)
Article in Radiation Oncology (July 2024)
Article in Clinical Radiology (May 2024)